Funding for this research was provided by:
DLR (NEURON-ERANET 01EW1109)
Received: 30 August 2017
Accepted: 3 January 2018
First Online: 22 January 2018
Ethics approval and consent to participate
: The study protocol was approved by the Ethics Committee of the Medical Faculty Mannheim of the University of Heidelberg and the Ethics Committee of the Medical Association of Rhineland-Palatinate and conducted in accordance with the Declaration of Helsinki. All mothers provided written informed consent prior to enrolment in the study.
: All mothers participating in the still-face situation gave their written consent to the filming and later pseudonymized analyses.
: Michael Deuschle and his research group received speaker and consulting fees from BristolMyers Squibb, Lundbeck Otsuka Pharma, and Servier. Michael Deuschle is a national coordinator and principal investigator of phase II and III trials for Lilly Pharma and Roche. The remaining co-authors have no competing interests to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.